Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Belgium-based Kingfisher Healthcare has received CE mark for its KFH Novo medical device, a breakthrough medical technology that enhances the healing of chronic wounds.
Subscribe to our email newsletter
KFH Novo utilizes Kingfisher’s Bio-Electric Stimulation Therapy to assist in and improve upon the healing of chronic wounds including venous leg ulcers, diabetic ulcers and pressure sores.
Henk Snyman, founder and CEO of Kingfisher Healthcare, said: “We are thrilled to offer physicians and patients a safe, non-invasive and cost-effective therapy designed to successfully treat several types of chronic wounds.”